Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Germany’s disastrous choice, FDA’s vape admission and other commentary

Por: New York Post Opinion October 03, 2022

thumbnail

After reviewing the many reasons to think Russia was behind last week’s sabotage of Nord Stream gas pipelines, deepening Europe’s energy crisis,  his schadenfreude: “European dependence on Russia for energy was always a bad idea because of the character and behavior of the regime in Moscow.” Indeed, “The notion that greater economic interdependence with Europe would tame Russia’s inclination toward geopolitical aggression is a... + full article



Similar News

ALS drug wins FDA approval despite questionable data

ABC News USA Health September 30, 2022

thumbnailWASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.Amylyx Pharmaceuticals said the Food and... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | WPLG Local 10


OnlyFans influencer Annabelle Knight thought she was dying after buying vape off the street in Bali

New York Post USA Life September 30, 2022

thumbnailAn Australian woman thought she was “going to die” and felt like she had “knives in her lungs” after buying a “dodgy” vape from a stranger in Bali. Gold Coast Australia woman Annabelle Knight was on a two-week holiday with friends when she had “the worst night of... + más

Influencer marketing stats: How creators have impacted businesses in 2021 | Business Insider

Race faker Rachel Dolezal’s nude OnlyFans photos leak on social media | New York Post


ALS drug wins FDA approval despite questionable data

WPLG Local 10 USA Politics September 30, 2022

thumbnailWASHINGTON – A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration approved... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | ABC News


ALS drug wins FDA approval despite questionable data

Associated Press USA Science September 30, 2022

thumbnailWASHINGTON (AP) — A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | ABC News


Author readings around Boston Sept. 25-Oct. 1

The Boston Globe USA Life September 22, 2022

thumbnailAll author appearances are virtual and free unless otherwise noted.SUNDAYJosh Funk (“”) and Carrie Finison (“”) read in person at 10:30 a.m. at . . . Susan Verde and Peter H. Reynolds (“”) read in person at 11 a.m. at . . . Kacen Callender (“”) is in conversation... + más

Dangerously wrong oxygen readings in dark-skinned patients spur FDA scrutiny | Ars Technica

The top 10 audiobooks on Audible.com | ABC News


FDA concedes delays in response to baby formula shortage

ABC News USA Health September 21, 2022

thumbnailWASHINGTON -- The Food and Drug Administration acknowledged Tuesday that its response to the U.S. infant formula shortage was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory.A 10-page report from the agency... + más

FDA concedes delays in response to baby formula shortage | Associated Press

Internal FDA report on infant formula crisis details shortfalls in response | ABC News


FDA concedes delays in response to baby formula shortage

Associated Press USA Politics September 21, 2022

thumbnailWASHINGTON (AP) — The Food and Drug Administration acknowledged Tuesday that its response to the U.S. was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory.A 10-page report from the agency offers its first... + más

FDA concedes delays in response to baby formula shortage | ABC News

Internal FDA report on infant formula crisis details shortfalls in response | ABC News



About iurex | Privacy Policy | Disclaimer |